JW Shinyak Corporation (067290) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.115x

Based on the latest financial reports, JW Shinyak Corporation (067290) has a cash flow conversion efficiency ratio of 0.115x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.46 Billion ≈ $3.03 Million USD) by net assets (₩38.73 Billion ≈ $26.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 067290 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

JW Shinyak Corporation - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how JW Shinyak Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

JW Shinyak Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JW Shinyak Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SuperCom Ltd F:50S	-0.056x
SRM Entertainment, Inc. Common Stock NASDAQ:SRM	0.000x
Orient Bell Limited NSE:ORIENTBELL	0.037x
Logan Ridge Finance Corp NASDAQ:LRFC	-0.015x
Sreeleathers Limited NSE:SREEL	0.037x
Prescient Therapeutics Ltd AU:PTX	-0.386x
Burberry Group PLC LSE:BRBY	0.403x
Klotho Neurosciences, Inc. NASDAQ:KLTO	-0.110x

Annual Cash Flow Conversion Efficiency for JW Shinyak Corporation (2007–2024)

The table below shows the annual cash flow conversion efficiency of JW Shinyak Corporation from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 067290 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩26.90 Billion ≈ $18.23 Million	₩8.44 Billion ≈ $5.72 Million	0.314x	+101.71%
2023-12-31	₩16.44 Billion ≈ $11.14 Million	₩2.56 Billion ≈ $1.73 Million	0.156x	+22.16%
2022-12-31	₩55.97 Billion ≈ $37.93 Million	₩7.13 Billion ≈ $4.83 Million	0.127x	-9.16%
2021-12-31	₩55.44 Billion ≈ $37.57 Million	₩7.77 Billion ≈ $5.27 Million	0.140x	+93.40%
2020-12-31	₩56.56 Billion ≈ $38.33 Million	₩4.10 Billion ≈ $2.78 Million	0.072x	+11.25%
2019-12-31	₩66.14 Billion ≈ $44.82 Million	₩4.31 Billion ≈ $2.92 Million	0.065x	-70.53%
2018-12-31	₩33.49 Billion ≈ $22.69 Million	₩7.40 Billion ≈ $5.02 Million	0.221x	+426.23%
2017-12-31	₩36.83 Billion ≈ $24.96 Million	₩-2.50 Billion ≈ $-1.69 Million	-0.068x	-451.98%
2016-12-31	₩38.60 Billion ≈ $26.16 Million	₩743.20 Million ≈ $503.66K	0.019x	+3608.61%
2015-12-31	₩40.23 Billion ≈ $27.26 Million	₩-22.08 Million ≈ $-14.96K	-0.001x	+98.99%
2014-12-31	₩42.46 Billion ≈ $28.77 Million	₩-2.31 Billion ≈ $-1.56 Million	-0.054x	-246.92%
2011-12-31	₩52.81 Billion ≈ $35.79 Million	₩1.95 Billion ≈ $1.32 Million	0.037x	-65.66%
2007-12-31	₩27.49 Billion ≈ $18.63 Million	₩2.96 Billion ≈ $2.01 Million	0.108x	--

About JW Shinyak Corporation

KQ:067290 Korea Pharmaceuticals

Market Cap

$50.62 Million

₩74.70 Billion KRW

Market Cap Rank

#21925 Global

#1334 in Korea

Share Price

₩1798.00

Change (1 day)

+1.30%

52-Week Range

₩1254.00 - ₩2480.00

All Time High

₩10766.98